CVE-2014-6721 | Pharmaguideline 1.2.0 X.509 Certificate cryptographic issues (VU#582497)
A vulnerability, which was classified as critical, was found in Pharmaguideline 1.2.0. This affects an unknown part of the component X.509 Certificate Handler. The manipulation leads to cryptographic issues.
This vulnerability is uniquely identified as CVE-2014-6721. The attack can only be initiated within the local network. There is no exploit available.